| 英文别名 |
2H-Indol-2-one,1,3-dihydro-3,3-bis(4-hydroxyphenyl)-;3,3-bis(4-hydroxyphenyl)-1H-indol-2-one;3,3-BIS(P-HYDROXYPHENYL)OXINDOLE;Oxyphenisatin;Oxyphenisatine;3,3-bis-(4-hydroxy-phenyl)-1,3-dihydro-indol-2-one;3,3-bis-(4-hydroxyphenyl)-2-indolinone;3,3-bis(4'-hydroxyphenyl)-2-oxo-2,3-dihydroindole;3,3-bis-(4-hydroxy-phenyl)-indolin-2-one;3,3-bis(p-hydroxyphenyl)-2-indolinone;4,4'-dihydroxydiphenylisatin;diphenolisatin;isatinbisphenol;isolax;lavema;neodrast;recolon;hoscolax;normalax;veripaque;propellax;phenolisatin;NS00005188;NCGC00262932-01;Isolax;5-21-13-00398 (Beilstein Handbook Reference);Tox21_113927;ZB1280;Phenolisatin;DTXCID3024528;CS-6312;Oxiphenisatinum;Nourilax;Recolon;EINECS 204-728-1;Critex;SR-01000196726;3,3-bis(4-hydroxyphenyl)indolin-2-one;2H-Indol-2-one, 1,3-dihydro-3,3-bis(4-hydroxyphenyl)-;Oxifenisatina;3,3-bis-(4-Hydroxyphenyl)-2(3H)-indolone;Normalax;BRN 0286070;NSC-59814;DB04823;UNII-3BT0VQG2GQ;1,3-Dihydro-3,3-bis(4-hydroxyphenyl)-2H-indol-2-one;2-Indolinone,3-bis(p-hydroxyphenyl)-;Isaphen (TN);Diphenolisatin;Oxyphenisatine (INN);D08326;F85523;NCGC00255866-01;Lavema;4,4'-Dihydroxydiphenylisatin;NSC 59814;OXYPHENISATINE [WHO-DD];DTXSID5044528;FT-0614032;Neodrast;3,3-Bis(4-hydroxyphenyl)oxindole;OXYPHENISATINE [MART.];Hoscolax;Propellax;MFCD00022794;Dihydroxyphenoloxindol;SCHEMBL8777299;Veripaque;HY-B2102;CHEBI:135358;OXYPHENISATINE [INN];Oxifenisatina [INN-Spanish];3,3-Bis(4-hydroxyphenyl)-1,3-dihydro-2H-indol-2-one #;2H-Indol-2-one,3-dihydro-3,3-bis(4-hydroxyphenyl)-;Isatinbisphenol;Oxyphenisatinum [INN-Latin];CHEMBL245807;CAS-125-13-3;AKOS003628613;3,3-Bis(p-hydroxyphenyl)-2-indolinone;Oxyphenisatine [INN:BAN];Q7116108;NCIOpen2_007896;3,3-Bis(p-hydroxyphenyl)oxindole;3,3-bis-(4-hydroxyphenyl)-oxindole;NSC59814;125-13-3;SR-01000196726-1;3BT0VQG2GQ;2-INDOLINONE, 3,3-BIS(p-HYDROXYPHENYL)-;Oxyphenisatinum;SCHEMBL239513;AS-76819;Oxindole, 3,3-bis(p-hydroxyphenyl)-;3,3-Bis(4-hydroxyphenyl)-oxindole;Tox21_301931;OXYPHENISATIN |
微信公众号
客服
